Literature DB >> 25585530

Genetic analysis of amyotrophic lateral sclerosis in the Slovenian population.

Katarina Vrabec1, Blaž Koritnik2, Lea Leonardis2, Leja Dolenc-Grošelj2, Janez Zidar2, Bradley Smith3, Caroline Vance3, Christopher Shaw3, Boris Rogelj4, Damjan Glavač1, Metka Ravnik-Glavač5.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a complex fatal neurodegenerative disease characterized by progressive degeneration and loss of upper motor neurons in the cerebral cortex and lower motor neurons in brainstem and spinal cord. We established the frequencies of mutations in 4 major ALS-associated genes, SOD1, TARDBP, FUS, and C9ORF72 in a representative cohort of 85 Slovenian patients with sporadic form of ALS. Pathogenic massive hexanucleotide repeat expansion mutation in C9ORF72 was detected in 5.9% of patients and was the most common cause of the disease. In the remaining 3 genes, we identified 4 changes in 3 patients, p.Val14Met in SOD1, silent mutation p.Arg522Arg in FUS, and p.Gly93Cys in SOD1 together with a novel synonymous variant c.990A>G (p.Leu330Leu) in TARDBP gene, respectively. This study represents the first genetic screening of major causative genes for ALS in a cohort of sporadic ALS patients from Slovenia and is according to our knowledge the first such study in Slavic population. Overall, we genetically characterized 8.2% sporadic ALS patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALS genetic analysis; C9ORF72; FUS; SOD1; Slovenian population; TARDBP

Mesh:

Substances:

Year:  2014        PMID: 25585530     DOI: 10.1016/j.neurobiolaging.2014.11.011

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  6 in total

1.  Comparison of the clinical and cognitive features of genetically positive ALS patients from the largest tertiary center in Serbia.

Authors:  Ivan V Marjanović; Biljana Selak-Djokić; Stojan Perić; Milena Janković; Vladimir Arsenijević; Ivana Basta; Dragana Lavrnić; Elka Stefanova; Zorica Stević
Journal:  J Neurol       Date:  2017-04-25       Impact factor: 4.849

2.  High frequency of C9orf72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis patients from two founder populations sharing the same risk haplotype.

Authors:  Orly Goldstein; Mali Gana-Weisz; Beatrice Nefussy; Batel Vainer; Omri Nayshool; Anat Bar-Shira; Bryan J Traynor; Vivian E Drory; Avi Orr-Urtreger
Journal:  Neurobiol Aging       Date:  2017-12-27       Impact factor: 4.673

3.  Genetic Variability of Inflammation and Oxidative Stress Genes Affects Onset, Progression of the Disease and Survival of Patients with Amyotrophic Lateral Sclerosis.

Authors:  Metka Ravnik-Glavač; Katja Goričar; David Vogrinc; Blaž Koritnik; Jakob Gašper Lavrenčič; Damjan Glavač; Vita Dolžan
Journal:  Genes (Basel)       Date:  2022-04-25       Impact factor: 4.141

4.  Differential Expression of Several miRNAs and the Host Genes AATK and DNM2 in Leukocytes of Sporadic ALS Patients.

Authors:  Katarina Vrabec; Emanuela Boštjančič; Blaž Koritnik; Lea Leonardis; Leja Dolenc Grošelj; Janez Zidar; Boris Rogelj; Damjan Glavač; Metka Ravnik-Glavač
Journal:  Front Mol Neurosci       Date:  2018-04-04       Impact factor: 5.639

5.  Phenotypic variability and neuropsychological findings associated with C9orf72 repeat expansions in a Bulgarian dementia cohort.

Authors:  Shima Mehrabian; Håkan Thonberg; Margarita Raycheva; Lena Lilius; Katya Stoyanova; Charlotte Forsell; Lena Cavallin; Desislava Nesheva; Eric Westman; Draga Toncheva; Latchezar Traykov; Bengt Winblad; Caroline Graff
Journal:  PLoS One       Date:  2018-12-14       Impact factor: 3.240

6.  Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls.

Authors:  Anja Kovanda; Lea Leonardis; Janez Zidar; Blaž Koritnik; Leja Dolenc-Groselj; Stanislava Ristic Kovacic; Tomaž Curk; Boris Rogelj
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.